Researchers implicate unique cell type in multiple sclerosis Medical Xpress Ongoing clinical trials have shown that daclizumab appears to help quiet the autoimmune response in MS patients, but its precise effects on the legions of cells that make up the immune system are not fully understood. The new study, published in ... |
